Navigation Links
Novavax CEO to Present at ACUMENBioFin's 5th Annual Global Healthcare Conference
Date:5/14/2008

ROCKVILLE, Md., May 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) Novavax today announced Chief Executive Officer Dr. Rahul Singhvi will present at ACUMENBioFin's 5th Annual Global Healthcare Conference at 5:05 am Eastern time (11:05 am CEST) on May 19 at the Meridien Beach Plaza Hotel in Monaco, the company announced today.

Dr. Singhvi will provide an overview of the company's strategy, research and development progress and its unique manufacturing solution. A link to an audio webcast of his presentation will be available at 5:05 am Eastern time (11:05 am CEST) on Monday, May 19 through the company's website, http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 30 days.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent recombinant vaccines utilizing a new, efficient manufacturing solution. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Novavax Reports First Quarter 2008 Financial Results
2. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
3. Novavax Opens Its First U.S. Vaccine Plant
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Novavax CEO to Present at BIO CEO & Investor Conference
8. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
11. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief ... ), Inc. has been selected for membership in ARCS Alumni Hall of ...
(Date:10/11/2017)... ... ... Personal eye wash is a basic first aid supply for any work environment, but most ... you rinse first if a dangerous substance enters both eyes? It’s one less decision, and ... unique dual eye piece. , “Whether its dirt and debris, or an acid or alkali, ...
(Date:10/11/2017)... Md. (PRWEB) , ... October 11, 2017 , ... ... digital pathology, announced today it will be hosting a Webinar titled, “Pathology is ... Advanced Pathology Associates , on digital pathology adoption best practices and how Proscia ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
Breaking Biology News(10 mins):